BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 996841)

  • 1. [Isoxazolylpenicillins. What conclusions can be drawn from their serum concentration].
    Melby K
    Tidsskr Nor Laegeforen; 1976 Nov; 92(33):1749-50. PubMed ID: 996841
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms responsible for the blood level differences of isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Rosenblatt JE; Kind AC; Brodie JL; Kirby WM
    Arch Intern Med; 1968 Apr; 121(4):345-8. PubMed ID: 5645708
    [No Abstract]   [Full Text] [Related]  

  • 3. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral penicillinase-resistant penicillins: contrasts between agents and assays.
    Bass JW; Bruhn FW; Merritt WT; Suttle DE; Jirka JH; Mesrobian RB; Berkenbaugh JT
    South Med J; 1982 Apr; 75(4):408-10. PubMed ID: 7041278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of therapy of patients with chronic renal insufficiency by the use of polysynthetic penicillins].
    Vasina TA; Iarmolinskiĭ IS; Levitskiĭ ER; Sagalovich GM
    Antibiotiki; 1971 Jun; 16(6):559-63. PubMed ID: 5000148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circulation of isoxazolyl penicillins in surgical patients].
    Iakovlev VP; Kopeĭko IP; Govorovich EA; Marshak AM; Nikishina OP
    Antibiotiki; 1971 Oct; 16(10):944-8. PubMed ID: 5138889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penicillin-stable penicillins: serum during therapy concentrations].
    Alestig K; Brandberg A
    Lakartidningen; 1971 Jul; 68(29):3274-7. PubMed ID: 5568827
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dicloxacillin, oxacillin, and nafcillin upon staphylococcal population and rate of healing of soft-tissue lesions.
    Hartman RE; Carleton J; Lustberg A; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1966; 6():64-8. PubMed ID: 5985303
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on therapy of staphylococcal infections in monkeys. V. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin.
    Saslaw S; Carlisle HN; Sparks J
    Am J Med Sci; 1970 Feb; 259(2):143-52. PubMed ID: 4984032
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin in streptococcal infections in monkeys.
    Saslaw S; Carlisle HN
    Am J Med Sci; 1970 Jun; 259(6):383-93. PubMed ID: 4987196
    [No Abstract]   [Full Text] [Related]  

  • 11. The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Marcy SM; Klein JO
    Med Clin North Am; 1970 Sep; 54(5):1127-43. PubMed ID: 4919148
    [No Abstract]   [Full Text] [Related]  

  • 12. The penicillins in ophthalmology.
    Records RE
    Surv Ophthalmol; 1969 Jan; 13(4):207-14. PubMed ID: 4974322
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of the effects of some inducers with or without protein binding properties on bioavailability of isoxazolylpenicillins in rats.
    Couvaris M; Galanopoulou P; Karageorgiou C; Theodosopoulos S; Varonos D
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):187-94. PubMed ID: 3816874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of the resistance behavior of staphylococci to isoxazolyl penicillins (oxa-, cloxa-, and dicloxacillin)].
    Matz K; Schassan HH; Faerber CH; Kornmüller KJ
    Zentralbl Bakteriol Orig A; 1974; 228(1):270-2. PubMed ID: 4154678
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of isoxazolyl penicillins and their metabolites in body fluids by high-performance liquid chromatography.
    Thijssen HH
    J Chromatogr; 1980 Sep; 183(3):339-45. PubMed ID: 7419651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antibiotic serum concentrations after intramuscular oxacillin and oral cloxacillin in children.
    Burckart GJ; Evans WE; Whitington GL
    Am J Hosp Pharm; 1978 Nov; 35(11):1380-2. PubMed ID: 707507
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of the concentration of penicillins in ascitic fluid from serum kinetics and protein binding of the antibiotics in serum and ascitic fluid of dogs.
    Gerding DN; Peterson LR; Salomonson JK; Hall WH; Schierl EA
    J Infect Dis; 1978 Aug; 138(2):166-73. PubMed ID: 681795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of isoxazolyl penicillins to human serum proteins.
    Ulmann U
    Arzneimittelforschung; 1977; 27(11):2136-8. PubMed ID: 580016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of penicillins: a pharmacokinetic view.
    Gibaldi M; Schwartz MA; Plaut ME
    Antimicrob Agents Chemother (Bethesda); 1968; 8():378-81. PubMed ID: 5735384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Binding of penicillins and serum protein. 2. Relationship between blood protein binding of penicillins and incorporation into erythrocytes].
    Nishida M; Matsubara T; Uemura T; Murakawa T; Yokota Y
    Jpn J Antibiot; 1970 Jun; 23(3):217-22. PubMed ID: 5312207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.